EAM Investors, LLC - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 165 filers reported holding AKERO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.6%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$2,374,467
+38.9%
50,856
+13.8%
0.44%
+31.0%
Q1 2023$1,709,725
-41.7%
44,687
-16.5%
0.34%
-44.6%
Q4 2022$2,932,458
+1.8%
53,512
-36.8%
0.61%
-3.0%
Q3 2022$2,881,000
+46.4%
84,607
+32.3%
0.63%
+34.0%
Q3 2020$1,968,00063,9280.47%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Skorpios Trust 3,271,829$125,180,17850.58%
COMMODORE CAPITAL LP 790,000$30,225,4004.60%
Redmile Group, LLC 2,044,389$78,218,3233.39%
SILVERARC CAPITAL MANAGEMENT, LLC 202,561$7,749,9843.20%
Ghost Tree Capital, LLC 275,000$10,522,0003.11%
Avidity Partners Management LP 2,447,000$93,622,2203.11%
Atlas Venture Life Science Advisors, LLC 594,251$22,736,0433.08%
Logos Global Management LP 400,000$15,304,0002.19%
Yiheng Capital Management, L.P. 1,125,791$43,072,7641.70%
Boxer Capital, LLC 831,495$31,8131.56%
View complete list of AKERO THERAPEUTICS INC shareholders